Clinical Trial to Evaluate Efficacy of GR-MD-02 for Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis

Clinical trial NCT02421094 · COMPLETED

Trial details

NCT number

NCT02421094

Sponsor

Galectin Therapeutics Inc.

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2015-09-01

Primary completion

2016-09-27

Enrollment

30

View on ClinicalTrials.gov